LEVETIRACETAM INJECTION USP SOLUTION Kanada - angielski - Health Canada

levetiracetam injection usp solution

sterimax inc - levetiracetam - solution - 100mg - levetiracetam 100mg

A3699-24 SPINAL 24G EUROPEAN PENCIL POINT - regional anesthesia kit Stany Zjednoczone - angielski - NLM (National Library of Medicine)

a3699-24 spinal 24g european pencil point - regional anesthesia kit

smiths medical asd, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - epinephrine is used to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of anesthetics. its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. epinephrine is used as a hemostatic agent. it is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. epinephrine injection can be utilized to prolong the action of anesthetics used in local and regional anesthesia. epinephrine is co

15986-21 SPINAL 24G SPROTTE- anesthesia conduction kit Stany Zjednoczone - angielski - NLM (National Library of Medicine)

15986-21 spinal 24g sprotte- anesthesia conduction kit

smiths medical asd, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - bupivacaine spinal is indicated for the production of subarachnoid block (spinal anesthesia). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. bupivacaine spinal (bupivacaine in dextrose injection, usp) is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia: 1.severe hemorrhage, severe hypotension or shock and arrhythmias, such as complete heart block, which severely restrict cardiac output. 2.local infection at the site of proposed lumbar puncture. 3.septicemia. lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural bl

8024-20 CONTINUOUS EPIDURAL 17G TUOHY- anesthesia conduction kit Stany Zjednoczone - angielski - NLM (National Library of Medicine)

8024-20 continuous epidural 17g tuohy- anesthesia conduction kit

smiths medical asd, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - lidocaine hydrochloride and epinephrine injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. epinephrine is used to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of anesthetics. its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. epinephrine is used as a hemostatic agent. it is also used in treating mucosal conge

15249-21 SPINAL 22G/25G QUINCKE- anesthesia conduction kit Stany Zjednoczone - angielski - NLM (National Library of Medicine)

15249-21 spinal 22g/25g quincke- anesthesia conduction kit

smiths medical asd, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - epinephrine is used to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of anesthetics. its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. epinephrine is used as a hemostatic agent. it is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. epinephrine injection can be utilized to prolong the action of anesthetics used in local and regional anesthesia. epinephrine is co

SPECTOGARD- spectinomycin sulfate injection, solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

spectogard- spectinomycin sulfate injection, solution

bimeda, inc. - spectinomycin sulfate (unii: bz0h4tlf9x) (spectinomycin - unii:93aki1u6qf) - indications and usage spectogard sterile solution is indicated for the treatment of bovine respiratory disease (pneumonia) associated with mannheimia haemolytica, pasteurella multocida, and histophilus somni. contraindications as with all drugs, the use of spectogard sterile solution is contraindicated in animals previously found to be hypersensitive to the drug.

LEVETIRACETAM injection solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

levetiracetam injection solution

fresenius kabi usa, llc - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 100 mg in 1 ml

TUBERSOL- tuberculin purified protein derivative injection, solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

tubersol- tuberculin purified protein derivative injection, solution

sanofi pasteur inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not be administered to: - persons who have had a severe reaction (e.g., necrosis, blistering, anaphylactic shock, or ulcerations) to a previous tst, - persons with documented active tuberculosis or a clear history of treatment for tb infection or disease, (9) - persons with extensive burns or eczema.

TUBERSOL- tuberculin purified protein derivative injection, solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

tubersol- tuberculin purified protein derivative injection, solution

a-s medication solutions - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not

TUBERSOL- tuberculin purified protein derivative injection, solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

tubersol- tuberculin purified protein derivative injection, solution

physicians total care, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol, tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (9) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied) tubersol should not